{"id":"becaplermin-users","safety":{"commonSideEffects":[{"rate":"10%","effect":"Application site reaction"},{"rate":"5%","effect":"Skin irritation"},{"rate":"5%","effect":"Pruritus"}]},"_chembl":{"chemblId":"CHEMBL1201556","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Becaplermin is a recombinant human platelet-derived growth factor (PDGF) that stimulates wound healing by promoting the proliferation and differentiation of keratinocytes and fibroblasts.","oneSentence":"Stimulates wound healing by promoting the proliferation and differentiation of keratinocytes and fibroblasts","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:22:34.837Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ulcerative wounds"}]},"trialDetails":[{"nctId":"NCT00518102","phase":"","title":"The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2003-01","conditions":"Diabetes Mellitus","enrollment":4431},{"nctId":"NCT01235260","phase":"","title":"Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2010-03","conditions":"Diabetes Mellitus, Foot Ulcer, Diabetic Foot","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Becaplermin users","genericName":"Becaplermin users","companyName":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","companyId":"johnson-johnson-pharmaceutical-research-development-l-l-c","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Stimulates wound healing by promoting the proliferation and differentiation of keratinocytes and fibroblasts Used for Ulcerative wounds.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}